Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

Date of beginning

Tuesday, 26 February 2019

Duration

3 days

City

Urayasu-shi

Country

Japan

Contact

Ally MacDonald

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo. AsiaTIDES 2019 keynote presentation lineup: 1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S 2) New Strategies and Technologies in Oligonucleotide Therapeutic Development- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals 3) The Chemistry behind Approved Oligonucleotide Therapeutics- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc. 4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences Prices:Conference Pass + Pre-Conference Workshop: USD 3023.0,Conference Pass: USD 2375.0 Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences Time: 9:00 am - 5:00 pm Venue details: Hilton Tokyo Bay, 1-8 Maihama, Urayasu-shi, 279-0031, Japan